a:head bio AG
PrivateLast Round
Early Funding
Apr 17, 2025
Total Funding Raised
$7.23M
Company Overview
a:head bio AG operates in Healthcare & Life Sciences and is based in Vienna. Its latest recorded funding round was an Early Funding round in April 2025.
a:head bio AG is a biotechnology company that develops novel therapeutics for the treatment of central nervous system disorders using a proprietary human cerebral organoid drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
a:head bio AG Comparables
Compare a:head bio AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Herophilus | 90% | |
| 28bio | 87% | |
| Synaxys | 86% |
For institutional investors. Book with your work email.
a:head bio AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 17, 2025 | ||||
| VC Round | Oct 9, 2024 | ||||
| Grant | Oct 25, 2019 | ||||
| Seed | Aug 7, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
a:head bio AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FFG Austrian Research Promotion Agency | Grant |
| red-stars.com data | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2026
Grew 54% QoQ, from 13 to 20 employees.
- Oct 9, 2024
Completed a VC Round funding round.
For institutional investors. Book with your work email.
a:head bio AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about a:head bio AG's valuation, stock price, and market status.
Is a:head bio AG a public or private company?
a:head bio AG is a private company.
What is the current stock price of a:head bio AG?
a:head bio AG is a private company, so its shares have no public market price. Caplight tracks a:head bio AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is a:head bio AG worth (valuation)?
Valuation information for a:head bio AG is not publicly available.
Can I buy a:head bio AG stock?
a:head bio AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was a:head bio AG's last funding round?
a:head bio AG's most recent funding round was Early Funding on April 17, 2025.
Who are the main investors in a:head bio AG?
Key investors in a:head bio AG include red-stars.com data.
Will a:head bio AG IPO soon?
No public IPO plans have been announced for a:head bio AG.
How can I track a:head bio AG secondary market activity?
Caplight tracks bids, offers, and trades in a:head bio AG's shares on secondary markets.